We are live on
!
Find out more
PAI
Palo Alto Investors Portfolio holdings
AUM
$654M
1-Year Est. Return
77.8%
This Fund
S&P 500
This Quarter
Est. Return
+20.62%
1 Year Est. Return
+77.8%
3 Year Est. Return
+127.05%
5 Year Est. Return
+199.24%
10 Year Est. Return
+2,229.57%
AUM
$954M
AUM Growth
+$107M
(+13%)
Cap. Flow
-$48.6M
Cap. Flow
% of AUM
-5.1%
Top 10 Holdings %
Top 10 Hldgs %
71.6%
Holding
36
New
4
Increased
11
Reduced
10
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
+$31M |
| 2 |
ITMN
INTERMUNE INC
ITMN
|
+$25.5M |
| 3 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
+$15.6M |
| 4 |
United Therapeutics
UTHR
|
+$11.9M |
| 5 |
EXAS
Exact Sciences
EXAS
|
+$10M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$124M |
| 2 |
VPHM
VIROPHARMA INC
VPHM
|
+$28.6M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$14.8M |
| 4 |
AEGR
Aegerion Pharmaceuticals
AEGR
|
+$3.11M |
| 5 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
+$2.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPPI
26
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $3.32M | 0.35% |
395,985
| – | – |
|
27
Cytokinetics
CYTK
$10.5B
| $1.98M | 0.21% |
261,544
| – | – |
|
|
XOMA
28
DELISTED
Xoma
XOMA
| $1.88M | 0.2% |
20,909
-5,225
| -20% | -$475K |
|
29
Prothena Corp
PRTA
$475M
| $1.79M | 0.19% |
88,500
| – | – |
|
|
HPTX
30
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
| $1.64M | 0.17% |
62,700
-20,900
| -25% | -$523K |
|
|
NXTM
31
DELISTED
NxStage Medical Inc.
NXTM
| $581K | 0.06% |
44,129
| – | – |
|
|
CELG
32
DELISTED
Celgene Corp
CELG
| $260K | 0.03% |
+3,380
| New | +$237K |
|
|
SPHS
33
DELISTED
Sophiris Bio, Inc.
SPHS
| $257K | 0.03% |
+55,000
| New | +$254K |
|
|
AEGR
34
DELISTED
Aegerion Pharmaceuticals
AEGR
| – | – |
-49,040
| Closed | -$3.11M |
|
|
DNDN
35
DELISTED
DENDREON CORPORATION
DNDN
| – | – |
-207,800
| Closed | -$856K |
|
Similar funds
AG
BL
PIM
ACA
PCM
HCM
ACM
DC
Palo Alto Investors's Q3 2013 Portfolio in Review
As of Q3 2013, Palo Alto Investors held 36 positions worth $954M, up 13% from $847M the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Palo Alto Investors withdrew a net $48.6M in Q3 2013, closing 2 positions and reducing 10 holdings. Its most notable exit was Aegerion Pharmaceuticals, an estimated $3.11M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 34% a quarter earlier.
Against the trend, Palo Alto Investors opened a new position in Exact Sciences worth $9.2M.
- Palo Alto Investors's largest Q3 2013 buy was Exact Sciences: 779,876 shares worth $9.2M.
- Palo Alto Investors added most to AUXILIUM PHARAMCEUTICALS INC in Q3 2013, an estimated $31M increase.
- Palo Alto Investors's biggest Q3 2013 reduction was ONYX PHARMACEUTICALS INC, cutting an estimated $124M.
- Palo Alto Investors fully exited Aegerion Pharmaceuticals in Q3 2013, selling an estimated $3.11M.
- Palo Alto Investors's ten largest holdings make up 72% of its $954M portfolio in Q3 2013.
- Palo Alto Investors opened 4 new positions and closed 2 in Q3 2013.
- Palo Alto Investors's portfolio value rose 13% quarter-over-quarter to $954M.
Based on Palo Alto Investors's 13F filing for Q3 2013, filed 13 Nov 2013.